DIDESMETHYL CITALOPRAM-D4
- CAS NO.:62498-69-5
- Empirical Formula: C18H17FN2O
- Molecular Weight: 296.34
- MDL number: MFCD07369325
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-04 17:34:40
What is DIDESMETHYL CITALOPRAM-D4?
Chemical properties
Pale Yellow Thick Oil
The Uses of DIDESMETHYL CITALOPRAM-D4
Didesmethyl citalopram-D4 is a metabolite of Citalopram, an inhibitor of serotonin (5-HT) uptake. Used as an antidepressant
Definition
ChEBI: Didemethylcitalopram is a member of benzenes and an organic amino compound.
Safety information for DIDESMETHYL CITALOPRAM-D4
DIDESMETHYL CITALOPRAM-D4 manufacturer
New Products
9-Mesityl-10-methylacridinium perchlorate Sulfapyridine Fmoc-OSu (R)-(-)-2-Amino-1-propanol Cyclobutanone 5-bromo-4-fluoro-2-nitrobenzaldehyde 4 pentyn 1 ol N-Vinylformamide Phenethyl cinnamate Pyrrolo[1,2-a]pyrimidine-6-carboxylic acid, 4,6,7,8-tetrahydro-4-oxo-, sodium salt (1:1), (6S) Ethyl 3-phenylpropanoate β-Bromostyrene Methacrylate-PEG-Methacrylate, Mn:35000 2,4-Dihydroxyacetophenone 2-Chloro 5-Fluoro Pyridine Vasicinone 2-Chloroisonicotinic Acid Tween 80 or Polysorbate 80 5-Bromo-1-Pentyne 1-(2-Methyl-5-nitrophenyl)guanidine Nitrate Methyl trans-4-Aminocyclohexanecarboxylate Hydrochloride N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide 4-Nitrobenzotrifluoride 2-Pentyn-1-oLRelated products of tetrahydrofuran







You may like
-
62498-69-5 NLT 95%View Details
62498-69-5 -
1191-95-3 Cyclobutanone 98+View Details
1191-95-3 -
Fmoc-OSu 98+View Details
82911-69-1 -
(R)-(-)-2-Amino-1-propanol 35320-23-1 98+View Details
35320-23-1 -
1191-95-3 Cyclobutanone 98+View Details
1191-95-3 -
213382-45-7 98+View Details
213382-45-7 -
Fmoc-OSu 98+View Details
82911-69-1 -
(R)-(-)-2-Amino-1-propanol 35320-23-1 98+View Details
35320-23-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
